The FDA has granted two Breakthrough Therapy Designations to telisotuzumab adizutecan (Temab-A, also known as ABBV-400), an ...
Now, the technology is making headlines again in cancer treatment. For the first time, a personalised mRNA cancer vaccine has ...
Local News Matters on MSN
New era in cancer treatment: UCSF scientist wins $1 million for KRAS breakthrough
A researcher at the University of California, San Francisco, has won a $1 million prize for an advance in cancer treatment, ...
AbbVie announced that the U.S. Food and Drug Administration (FDA) has granted two Breakthrough Therapy Designations (BTDs) for telisotuzumab adizutecan (Temab-A; ABBV-400) in colorectal cancer (CRC) ...
The FDA approved the medication more than six months ahead of schedule after trials showed it nearly doubled median survival ...
The approach is still experimental, but a newly approved drug, advances in early detection, and promising research involving ...
Kevan Shokat, PhD, a professor of Cellular and Molecular Pharmacology at UC San Francisco who discovered how to disable KRAS, ...
New research shows that BH3 mimetic drugs targeting antiapoptotic Bcl-2 family proteins can sensitize bladder cancer cells ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. A new targeted treatment for pancreatic cancer has been approved by the FDA after impressive ...
Merck and Moderna’s success with a personalized cancer vaccine designed to keep melanoma at bay opens a new avenue of treatment that doctors hope will work against many types of tumors. Unlike ...
Revolution Medicines received breakthrough therapy designation from the Food and Drug Administration for its treatment of pancreatic cancer. The designation is for Rasonque to treat metastatic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results